The average effective dose of 4-amino-5-(furan-2-yl)-4H-1 ,2,4-triazole-3-thiol in experimental hepatitis

Authors

  • I. M. Belay
  • E. O. Mihayluk
  • V. V. Parchenko
  • O. I. Panasenko
  • E. G. Knysh

DOI:

https://doi.org/10.14739/2310-1210.2014.2.25445

Keywords:

triazole derivatives, experimental hepatitis, average effective dose, probit-analysis

Abstract

The work presents the research of the average effective dose of 4-amino-5-(furan-2-yl)-4H-1,2,4-triazole-3-thiol in experimental hepatitis. Recalculations conducted for the human with the sensitivity coefficient, average effective dose for human is 13,87 mg/kg.

References

Stefanov O.V. Doclinicheskiye doslidzhenia likarskikh zahodiv [Preclinic investigation medicines: metodic recomendation]. Kiev, Avicena 2001. 528 p.

Morosov S.Yu. Hepatoprotectors in practic work of clinic doctor. Russky medicinsky zhurnal, 2009; № 11 (1): 25.

Nikitin I.G. Hepatoprotectors: miths and real opportunity. Pharmoteka, 2007., № 12 (147): 14-18.

Polunina T.E., Mayev I.V., Polunina E.V. Hepatologiya dlia practicheskogo vracha [Hepatology for practic doctor]. Moscow, Avtorckaya academiya 2009., 350 p.

Platonov A.G., Ahalaya M.Ya. Dosovaya zavisimost postluchevoy zgibeli. Raschet poluletalnoy dozy LD50 metodom probitanalisa [Dose dependence of the post-radiation death. Calculation sublethal dose LD50 by probit analysis]., Mascow, MGU, 2006., 33 p.

Prozorovskit V.B. Statistic analysis of the results of pharmacological studies., Psikhofarmakologiya biologiya narkologiya, 2007., № 7 (3-4): 2090-2120.

Rybolovlev Yu.R., Rybolovlev R.S. Dosing substances for mammalian constant biological activity. Zhurnal AMN SSSR, 1979., №247 (6): 1513-1516.

Tkach S.M. Effectiveness and safety hepatoprotectors terms of evidence-based medicine., Zdorovye ukrainy, 2009., № 6: 7-10.

Donnelly KL, Smith CI, Schwarzenberg SJ et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with non–alcoholic fatty liver disease.// J Clin Invest 2005; 115(5):1343–51.

Downloads

How to Cite

1.
Belay IM, Mihayluk EO, Parchenko VV, Panasenko OI, Knysh EG. The average effective dose of 4-amino-5-(furan-2-yl)-4H-1 ,2,4-triazole-3-thiol in experimental hepatitis. Zaporozhye Medical Journal [Internet]. 2014Jun.19 [cited 2024Nov.2];16(2). Available from: http://zmj.zsmu.edu.ua/article/view/25445

Issue

No. 2 (2014): Zaporozhye medical journal

Section

Problems of pharmacy

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)